SCHEMBL5464797

SCHEMBL5464797

COc1ccccc1NC(=O)Nc1ccc(N2CCNCC2)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.65
KMT2A Q03164 7/20 0.65
ALDH1A1 P00352 3/20 0.65
MAPT P10636 10/20 0.53
RAB9A P51151 9/20 0.53
NPC1 O15118 8/20 0.53
HTT P42858 2/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
TP53 P04637 2/20 0.52
PKM P14618 1/20 0.52
TSHR P16473 1/20 0.52
LMNA P02545 2/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GLA P06280 1/20 0.48
ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458175 0.88 S1PR1 (0.58) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5456763 0.88 RAB9A (0.57) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5467434 0.87 GAA (0.55) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5549915 0.87 MEN1 (0.64) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5458483 0.83 MEN1 (0.59) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5460083 0.82 RAB9A (0.77) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5458255 0.79 ALDH1A1 (0.53) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5459843 0.79 RAB9A (0.55) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5459036 0.78 RAB9A (0.57) MEN1KMT2AALDH1A1MAPTRAB9A
SCHEMBL5456043 0.78 GFER (0.58) MEN1KMT2AALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 MEN1 1828/4885KMT2A 1350/4885ALDH1A1 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.